What 23andMe business troubles could mean for users' genetic data
Companies, 23andMe included, also have a responsibility to notify consumers of changes and get "consumers' affirmative ...
Myriad Genetics price target lowered to $24 from $34 at Scotiabank
Scotiabank lowered the firm’s price target on Myriad Genetics (MYGN) to $24 from $34 and keeps an Outperform rating on the shares. The ...
News Medical on MSN3 天
Genetic links between osteoarthritis and cardiovascular disease reveal hidden common risks
Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...
23andMe customer? What to know about the privacy of your genetic data.
Me, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what ...
Myriad Genetics (MYGN) Gets a Buy from Scotiabank
In a report released today, Sung Ji Nam from Scotiabank maintained a Buy rating on Myriad Genetics (MYGN – Research Report), with a price ...
News Medical on MSN8 天
Genetic and environmental drivers shape early type 1 diabetes risk in children
Researchers from the TEDDY study highlight how specific genetic and environmental factors may drive early autoimmunity linked ...
腾讯网3 天
张海滨团队Trends in Genetics综述丨海洋无脊椎动物对深海热液极端环境 ...
▲ 点击上方蓝字关注CellPress细胞科学 ▲生命科学Life science近日，Cell Press细胞出版社旗下权威综述期刊Trends in Genetics发表了中国科学院深海科学与工程研究所张海滨研究员团队撰写的文章“Genetic ...
Myriad Genetics股票目标价在联合健康更新后保持不变
周一，TD Cowen维持Myriad Genetics (NASDAQ:MYGN)股票的持有评级，目标价保持在$30.00不变。这一决定是在联合健康(UNH)最近更改药物基因检测政策之后做出的。 具体而言，UNH更新了其指南，排除了对多基因检测的覆盖，包括Myriad Genetics的GeneSight产品，该产品用于指导抗抑郁药物治疗。在这一公告之后，Myriad Genetics的股价下跌 ...
News Medical on MSN1 天
deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk
New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing ...
Pokémon TCG Pocket Players Vote Charizard ex the Best Card in Genetic Apex
Pokémon Trading Card Game Pocket players have voted Charizard ex the best card in the game, with his meta game rival Mewtwo ...
Yahoo Finance7 天
CS Genetics Unveils SimpleCell™: A New Era in Single-Cell Genomics
DENVER, Nov. 6, 2024 /PRNewswire/ -- CS Genetics, a leader in next-generation single-cell genomics, today announced the launch of SimpleCell™ 3' Gene Expression kits, its first commercial ...
Atossa Genetics股票维持买入评级，因试验结果积极
周二，H.C. Wainwright维持Atossa Genetics (NASDAQ:ATOS)的买入评级和6.00美元的股票目标价，此前该公司宣布了一项二期研究的积极结果。 这项研究聚焦于Z-endoxifen，旨在降低绝经前女性的乳腺密度(MBD)。这项名为KARISMA-Endoxifen的试验涉及240名参与者，分为三组，每组分别接受每日1毫克剂量、每日2毫克剂量或安慰剂，持续六个月。